Hematopoietic Stem Cell Transplantation Clinical Trial
Official title:
Myths and Misconceptions About HSCT in a Limited Resource Region: Current Situation and Future Directions
Verified date | December 2021 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aimed to assess myths and misconceptions about hematopoietic stem cell transplantation, among students of medical colleges and to evaluate the value of an educational program in correcting those misconceptions. 218 undergraduate medical and nursing students included in this study. An intervention Quasi Experimental study design (pre/post-test) was used for this work.
Status | Completed |
Enrollment | 218 |
Est. completion date | December 17, 2021 |
Est. primary completion date | December 10, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: - Willingness to participate in the study - Good ECOG performance status - Intact physical and mental health Exclusion Criteria: - HSCT team - Drug users |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of medicine | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | detect further needs for advancement of health education by using structured questionnaire (Part II and Part III) willingness regarding hematopoietic stem cell transplantation and misconceptions about hematopoietic stem cell transplantation | the educational program corrects myths and misconceptions about hematopoietic stem cell transplantation of the study sample and increases their willingness regarding hematopoietic stem cell transplantation which enhance the needs for advancement of health education about bone marrow transplantation at Assiut University. | one session for medical students and one session for nursing students, each session will take up to 1 hour | |
Primary | Assess myths and misconceptions about hematopoietic stem cell transplantation using structured questionnaire about misconceptions and willingness regarding hematopoietic stem cell transplantation | 5th year undergraduate medical students and 4th year undergraduate nursing students will be asked about their misconceptions about hematopoietic stem cell transplantation including bone marrow transplantation, bone marrow donation, and stem cell banking. | one session for medical students and one session for nursing students, each session will take up to 1 hour | |
Secondary | evaluate the value of an educational program by using structured questionnaire (Part II and Part III) willingness regarding hematopoietic stem cell transplantation and misconceptions about hematopoietic stem cell transplantation | the educational program corrects myths and misconceptions about hematopoietic stem cell transplantation of the study sample and increases their willingness regarding hematopoietic stem cell transplantation | one session for medical students and one session for nursing students, each session will take up to 1 hour |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00766883 -
Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant
|
Phase 2 | |
Recruiting |
NCT06148610 -
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
|
||
Recruiting |
NCT04690933 -
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
|
||
Completed |
NCT02564458 -
Fitness in Allogeneic Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT02543073 -
MSC for Treatment of Interstitial Lung Disease After Allo-HSCT
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT01714557 -
Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation
|
N/A | |
Completed |
NCT00701688 -
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 1 | |
Completed |
NCT00023530 -
Blood and Marrow Transplant Clinical Research Network
|
N/A | |
Recruiting |
NCT04092309 -
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
|
N/A | |
Completed |
NCT00000603 -
Cord Blood Stem Cell Transplantation Study (COBLT)
|
Phase 2 | |
Completed |
NCT02663622 -
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
|
Phase 2 | |
Recruiting |
NCT04937634 -
Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation
|
Phase 1 | |
Recruiting |
NCT04203108 -
ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis
|
Phase 4 | |
Withdrawn |
NCT03279133 -
Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.
|
Phase 4 | |
Completed |
NCT03654599 -
Effects of Digital Stories Intervention on Psychosocial Well-being
|
N/A | |
Completed |
NCT02241005 -
Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
|
N/A | |
Recruiting |
NCT03689465 -
PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis
|
Phase 4 | |
Recruiting |
NCT04868786 -
Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation
|
Phase 1 | |
Recruiting |
NCT03010579 -
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
|
Phase 4 | |
Active, not recruiting |
NCT00959140 -
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
|
N/A |